Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Transaction in Own Shares

27 Mar 2025 07:00

RNS Number : 3865C
Marlowe PLC
27 March 2025
 

27 March 2025

 

Marlowe plc

 

Transaction in Own Shares

 

Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical services, announces that, in accordance with the terms of its share buyback programme announced on 22 May 2024, the Company has purchased 70,000 ordinary shares of 50 pence each in the capital of the Company (the "Shares") in the market at a volume weighted average price of 324.69 pence per Share through Cavendish Capital Markets Limited ("Cavendish"). The Shares acquired will, in due course, be cancelled.

 

 

Aggregated Information

 

Date of Purchase:

26/03/2025

Aggregate Number of Shares Purchased:

70,000

Lowest Price Paid per Share (pence):

324.00

Highest Price Paid per Share (pence):

324.80

Volume-Weighted Average Price Paid per Share (pence):

324.69

 

 

Following the cancellation of Shares, Marlowe will have 80,879,240 ordinary shares of 50 pence each in issue and no ordinary shares are held in treasury. This figure 80,879,240 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Individual Transactions

Number of Shares purchased

Transaction price (pence per Share)

Time of transaction

Venue

60,000

324.80

15:14

AIMX

10,000

324.00

16:19

AIMX

 

 

 

For further information:

 

 

 

Marlowe plc

Lord Ashcroft, Interim Non-Executive Chair

Adam Councell, Chief Financial Officer

Benjamin Tucker, Head of Group Reporting

 

www.marloweplc.com

Tel: +44 (0)20 3813 8498

IR@marloweplc.com

 

Cavendish Capital Markets Limited (Nominated Adviser & Broker)

Ben Jeynes

George Lawson

Tel: +44 (0)20 7220 0500

FTI Consulting

Nick Hasell

Alex Le May

Tel: +44 (0)20 3727 1340

 

About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBIGDXSGDDGUL
Date   Source Headline
4th Jul 202512:26 pmRNSForm 8.3 - Mitie Group Plc
4th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
4th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Mitie Group Plc
4th Jul 202511:46 amRNSForm 8.5 (EPT/RI)
4th Jul 202510:17 amRNSHolding(s) in Company
4th Jul 20259:41 amRNSForm 8.5 (EPT/NON-RI)
4th Jul 20257:00 amRNSHolding(s) in Company
3rd Jul 20253:25 pmBUSForm 8.3 - Marlowe plc
3rd Jul 20252:51 pmRNSForm 8.3 MARLOWE PLC
3rd Jul 20252:20 pmRNSForm 8.3 - Mitie Group Plc
3rd Jul 20251:52 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
3rd Jul 20251:46 pmRNSForm 8.3 - Mitie Group Plc - Replacement
3rd Jul 20251:14 pmRNSForm 8.3 - Mitie Group plc
3rd Jul 202512:23 pmGNWForm 8.3 - [MARLOWE PLC - 02 07 2025] - (CGWL)
3rd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
3rd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc
3rd Jul 202511:53 amRNSForm 8.5 (EPT/RI)
3rd Jul 202510:35 amRNSForm 8.5 (EPT/NON-RI)
3rd Jul 202510:22 amRNSHolding(s) in Company
3rd Jul 20259:21 amRNSForm 8.3 - Marlowe PLC
3rd Jul 20257:01 amRNSForm 8 (DD) - Mitie Group plc
3rd Jul 20257:00 amRNSPublication of Annual Report
2nd Jul 20253:15 pmRNSForm 8.3 MARLOWE PLC
2nd Jul 20253:03 pmRNSForm 8.3 - Mitie Group Plc
2nd Jul 20252:55 pmGNWForm 8.3 - [MARLOWE PLC - 01 07 2025] - (CGWL)
2nd Jul 20252:51 pmGNWForm 8.3 - [MARLOWE PLC - 30 06 2025] - (CGWL)
2nd Jul 20252:13 pmBUSForm 8.3 - Marlowe PLC
2nd Jul 20251:56 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
2nd Jul 202512:42 pmRNSForm 8.3 - MITIE GROUP PLC
2nd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
2nd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Mitie Group Plc
2nd Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc
2nd Jul 202511:57 amRNSForm 8.5 (EPT/RI) - Marlowe PLC
2nd Jul 202511:33 amGNWForm 8.3 - Marlowe Plc
2nd Jul 20257:00 amRNSForm 8 (DD) - Mitie Group plc
1st Jul 20253:22 pmRNSForm 8 (DD) - Mitie Group plc
1st Jul 20252:57 pmRNSForm 8.3 MARLOWE PLC
1st Jul 20252:55 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
1st Jul 20252:12 pmBUSForm 8.3 - Marlowe PLC
1st Jul 20251:51 pmRNSForm 8.3 - Mitie Group Plc
1st Jul 20251:23 pmRNSForm 8.5 (EPT/RI) - Marlowe PLC
1st Jul 202512:55 pmRNSForm 8.3 - MITIE GROUP PLC
1st Jul 202512:30 pmRNSHolding(s) in Company
1st Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
1st Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Mitie Group Plc
1st Jul 202510:16 amRNSForm 8.5 (EPT/NON-RI)
30th Jun 20252:53 pmBUSForm 8.3 - Marlowe PLC
30th Jun 20252:42 pmRNSForm 8.3 - MITIE GROUP PLC
30th Jun 20252:16 pmRNSForm 8.3 - Marlowe PLC
30th Jun 20251:49 pmGNWForm 8.3 - Marlowe Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.